Login

Alan Beasley, CEO, Hydroponics Company Ltd 00:00:00

Share On Facebook Share On Twitter

OnMarket IPO: The Hydroponics Company (ASX:THC) interview with Alan Beasley & Andrew Beehag

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
China's Post-COVID Economic Recovery: Investment, Policy, and Market Insights
00:10:00
Metallic Minerals Corp.: Unlocking Value in Precious and Base Metals | GREG JOHNSON, Chief Executive Officer of Metallic Minerals
00:10:00
Waterberg Palladium Project Overview: Unveiling the World's Premier Undeveloped Palladium Asset
00:00:00
Medical device, used in patients undergoing breast reconstruction following a mastectomy - Scott Dodson, CEO, AirXpanders Inc.
00:10:00
Securing NHS Digital: MFA Compliance Webinar | Stuart McGregor , CEO of Osirium Technologies Plc
00:10:00
First Vanadium: Advancing High-Grade Deposits in Nevada - Insights from the One-to-One Mining Investment Conference in New York
00:10:00
Kobo Resources: Advancing Gold Exploration in Cote d'Ivoire
00:10:00
Indiana Resources: Advancing Gold Exploration in South Australia & Arbitration Against Tanzania
00:10:00
Exploring the Shift Towards Energy Efficiency and Collective Self-Consumption in Response to the Energy Crisis | Orazio Iacono, CEO, Hera SpA.
00:10:00
Cramer interviewed Bill Staples, CEO of New Relic, during a CNBC Investing Club session.
00:10:00
Insights from an Executive on Renewable Energy, Market Dynamics, and Social Responsibility in Today's Economic Climate | João Manso Neto, CEO, Greenvolt Energias Renovaveis SA.
00:10:00
ITT CEO Acknowledges Women Engineers' Impact | Luca Savi - CEO of ITT Inc.

© 2017 - Neuhu+